title: VP-16, cisplatin, doxorubicin, and bleomycin in metastatic Merkel cell carcinoma. Report of a case with long-term remission.
abstract: A complete response with combination chemotherapy was obtained in a patient with metastatic Merkel cell carcinoma. This complete response lasted 15 months. This case report demonstrates the chemosensitivity of this metastatic disease when treated with combination chemotherapy.
authors.affiliation: Medical Oncology Service, Centre H. Becquerel, Rouen, France.
authors.forename: M
authors.initials: M
authors.lastname: Azagury
authors.forename: B
authors.initials: B
authors.lastname: Chevallier
authors.forename: D
authors.initials: D
authors.lastname: Atlan
authors.forename: Y
authors.initials: Y
authors.lastname: Graic
authors.forename: J P
authors.initials: JP
authors.lastname: Dayot
authors.forename: E
authors.initials: E
authors.lastname: Thomine
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001761:Bleomycin / Q000008:administration & dosage; D015266:Carcinoma, Merkel Cell / Q000188:drug therapy* / Q000556:secondary; D002945:Cisplatin / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D006801:Humans; D008297:Male; D008875:Middle Aged; D012074:Remission Induction; D012878:Skin Neoplasms / Q000188:drug therapy*
chemical_list: D001761:Bleomycin; D005047:Etoposide; D004317:Doxorubicin; D002945:Cisplatin